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SPERM YOU CAN BANK ON; A PROPOSED FEDERAL REGULATORY SCHEME 
TO INCREASE CONSUMER PROTECTION IN THE SPERM DONATION INDUSTRY 
Jessica Stookey  
 
I. INTRODUCTION 
 Sperm donation is a well-accepted practice in the 21st century.  It provides a comedic 
plot line for more than a few popular movies where some mishap occurs in the sperm donation 
process.  In The Switch Jennifer Anniston unknowingly inseminates herself with her friend’s 
sperm instead of her selected donor’s sperm; in Delivery Man Vince Vaughn discovers that an 
error at a sperm bank led his sperm donations to conceive 533 children.  In each of these movies 
all parties involved—donor, parents, and children—get a happy ending and learn some lesson 
about the meaning of family and love.  However, incidents such as these do not just exist in feel-
good comedies.  Mishaps involving sperm donation are not uncommon.  Recent trends with 
direct to consumer testing, social media, and openness about the topic of sperm donation have 
brought the incidents surrounding sperm donation into the public eye. 
 Sperm banks have given mothers the wrong sperm.1  Donors have lied about critical 
pieces of medical and personal history.2  Sperm banks have failed to disclose information about 
donors that any parent would want to know about the biological father of their child.3  In almost 
any other industry these incidents would result in lawsuits.  In the medical industry, such 
mistakes would result in malpractice claims.  In typical commerce, these “product” mix ups 
would constitute a breach of contract or the basis of a products liability claim.  But in the unique 
 
1 See infra at 49 
2 See infra at 42 
3 See infra at 43 
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industry of sperm donation the alleged injury in these cases is ultimately the existence of a 
child—a child genetically different than the child the parents had wanted.  There are huge ethical 
concerns with recognizing this child as a legal injury.   
 The reality is that the sperm donation industry operates largely without regulation to 
prevent or deter these kinds of incidents.  Existing Food and Drug Administration (FDA) 
regulation offers little protection to consumers, and potential legal remedies are limited at best.  
For decades the sperm banking industry, and the assisted reproductive technology (ART) 
industry as a whole, was considered by many to be the “wild west” of the healthcare field.  But 
the prominence of sperm donation in modern family planning demands the enactment of a new 
regulatory scheme that protects parents and children from trying to squeeze their unique “injury” 
into the existing parameters of common law remedies.  This comment will discuss the current 
state of the sperm donation industry from a legal standpoint and the issues within it, and then 
recommend a regulatory scheme that could help protect the people who rely on the industry to 
start their families.  
II. BACKGROUND 
A. Increased Reliance on Sperm Donors 
 The increased use of and discussion surrounding sperm donation is largely linked to 
increased infertility rates, both medical and “social” infertility.  Couples are medically infertile if 
they are unable to conceive after trying for one year.4  One in six couples experiences infertility.5  
Male infertility—where the problem in conceiving is due to the male partner—is the sole cause 
 
4 World Health Organization, Infertility, https://www.who.int/reproductivehealth/topics/infertility/definitions/en/ 
(last visited Fall 2019).  
5 American Pregnancy Association, Male Infertility, https://americanpregnancy.org/infertility/male-infertility/ (last 
visited Fall 2019). 
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of infertility in about 20% of all infertility cases and is a contributing factor in about 30% of 
cases.6  Male infertility usually occurs because of sperm abnormalities, inadequate numbers of 
sperm, or ejaculation problems.7  These issues can be a result of a number of different disorders, 
but the exact cause of these issues is unknown in almost half of all male infertility cases.8  
Studies indicate that rates of male infertility are increasing,9 and with it the need for heterosexual 
couples to rely on sperm donation to begin their families.10   
 “Social” infertility, sometimes called “circumstantial” infertility, is a term used to 
describe couples or individuals who must rely on assisted reproductive technology (ART) to 
reproduce because of their lifestyle as opposed to a medical condition.11  Changing social norms, 
values, and lifestyles have caused more single women to procreate without a partner.12  Improved 
social acceptance and recognition of legal rights has led more same-sex couples to have 
biological children.13  Single women and same-sex female couples will, of course, have to rely 
on sperm donation to conceive a child.  Heterosexual couples may also choose to use a sperm 
donor when genetic testing or family background indicates that the male has a high probability of 





9 Researchers disagree over whether this increase is actually attributable to some environmental factor, or just an 
increase in reporting as more men consult with their doctors about infertility. 
10 Ashley Fetters, Sperm Count Continues to Fall, The Atlantic (Oct. 12, 2018), 
https://www.theatlantic.com/family/archive/2018/10/sperm-counts-continue-to-fall/572794/ 
11 Your Fertility Friend, Social Infertility, https://yourfertilityfriend.com/social-infertility/ (last visited Fall 2019). 
12 Id. 
13 Id. 
14 Mayo Clinic, Sperm Donation, https://www.mayoclinic.org/tests-procedures/sperm-donation/about/pac-20395032 
(last visited Fall 2019). 
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 It is difficult to find exact and accurate statistics reporting the number of children born 
through sperm donation.15  The most reliable and commonly used statistic is from 2010, showing 
that 30,000-60,000 of the 4 million babies born in the US that year were born through sperm 
donation.16  However, social stigmas and the lack of nationalized reporting system mean that 
many births from sperm donation likely go unreported indicating that the true number is likely 
much higher.  
B. The Sperm Donation Process 
i. Donor Perspective 
In order to apply to be a sperm donor, a man must be: (1) between 19 and 38 years old, 
(2) currently attending or having graduated from college, (3) in good health, and (4) legally 
allowed to work in the United States.17  First, a man interested in becoming a donor must fill out 
an initial screening application online detailing his personal information, family background, and 
education.18  Second, after passing the initial screening, the man must provide a semen sample.19  
Third, if he passes the lab tests, the man must have a physical examination, meet with a genetic 
counselor, complete a donor profile, and provide three photographs of the donor as a child.20  If 
the potential donor completes these steps without issue, then the man becomes a qualified sperm 
 
15 Wendy K.R. blog post “How Many Donor Offspring Are Really Out There Donor Sibling Registry 
https://www.donorsiblingregistry.com/blog/how-many-donor-offspring-are-really-out-there/ (discussing the lack of 
reporting and accurate numbers in the sperm donation industry and how outdated the “30,000-60,000 per year” is.  
16 Ashley Fetters, The Overlooked Emotions of Sperm Donation, The Atlantic (Jul. 9, 2019), 
https://www.theatlantic.com/family/archive/2018/07/sperm-donations-emotional-consequences/564587/. 
17 Sperm Bank, Donor Requirements, https://www.spermbank.com/how-it-works/sperm-donor-requirements (last 
visited Fall 2019). 
18 Sperm Bank, Donor Screening Process, https://www.spermbank.com/how-it-works/donor-screening-process (Last 
accessed Fall 2019). 
19 Id. The semen must be screened for infectious disease. Some sperm banks screen semen for certain genetic issues 




donor.21  Most facilities request that each donor donate two to three times per week for at least a 
year and require the donor to be tested every three months for infectious disease.22  
 Sperm banks cannot pay donors for sperm itself; the actual specimen must be legally 
considered a donation.  However, sperm banks pay donors up to $1500 monthly for their “time 
and expenses” to get around the restriction on purchasing sperm.23  One sperm bank explains on 
their website, “Sperm donors also receive periodic incentives such as movie tickets or gift 
certificates for extra time and effort expended.” 24 
 At some point during this process the donor signs a contract legally giving up all parental 
rights and responsibilities for any children resulting from their donation.25 
ii. Parent Perspective 
 After parents decide to use a sperm donor, they must begin the process of choosing the 
donor.  Many fertility clinics maintain lists of preferred sperm banks.26  Parents use the sperm 
bank website to view donor profiles.27  The design of these websites is quite similar to any online 
retail website where shoppers can narrow down their search by specific criteria.  Parents can 
search based on a variety of characteristics: age, ethnicity, hair color, eye color, blood type, 
height, educational degree, etc.28  Profiles include these basic traits and known family history of 




23 Sperm Bank, Sperm Donor Pay, https://www.spermbank.com/why-donate/sperm-donor-pay (Last Accessed Fall 
2019). 
24 Id. 
25 Sperm Bank, Donor Screening Process, https://www.spermbank.com/how-it-works/donor-screening-process (Last 
accessed Fall 2019). 







Parents can pay the sperm bank extra to get donor childhood photos, voice recordings, answers 
to questionnaires, personality types, and sometimes even adult photos.30  
 After choosing a donor the parents order the sperm, usually to their fertility clinic.31  The 
sperm bank delivers sperm in a special temperature-controlled container.32  At the clinic a doctor 
either directly inseminates the mother with the sperm, or introduces the sperm to the egg in a 
laboratory before transferring the fertilized egg into the uterus.33 
iii. Costs 
 Each vial of “washed” sperm costs $800-$1000 and fertility clinics recommend ordering 
three to six vials per cycle.34  Many women do not get pregnant from one cycle so parents must 
pay this amount for as many cycles as it takes to get pregnant.  This price also does not include 
shipping, storage, and browsing fees.35  As mentioned above, there can be additional costs for 
additional information about each sperm donor the parents are considering.36  These numbers do 
not include any of the medical costs for consultations, inseminations, or any additional fertility 
treatments the mother may need.  Insurance companies may or may not cover some of these 
costs depending on the state and particular insurance plan.37 
C. Recent Cases and Controversies In The Sperm Donation Industry 
i. Zelt v. Xytex Corp.  
 
30 Id. 




34 “Washed” sperm is a specimen of sperm that has gone through several laboratory procedures to eliminate dead, 






 In an 11th Circuit case decided in February, 2019, the Zelts sued a sperm bank, Xytex.38  
The Zelts had two children both conceived through insemination with the sperm of Donor #9623 
which they purchased through Xytex.39  Xytex’s website promised they would screen potential 
sperm donors through interviews and physical examinations.40  The Zelts decided on this 
particular donor because Xytex stated that the donor was a Ph.D. candidate, had an IQ of 160, a 
“nearly perfect” medical and mental health history, and no criminal background.41  Years after 
their children were born the Zelts discovered that many of the representations about Donor 
#9623—James Aggeles—were untrue: Aggles was diagnosed with schizophrenia and had been 
repeatedly hospitalized for mental health reasons and drug use; he was considered disabled by 
social security; had a felony conviction; was never enrolled in a Ph.D. program, and had only 
finished college years after the Zelts purchased the sperm; and he had lied about his IQ.42  
Aggles claimed that he had been encouraged to lie by a Xytex employee so that he would be 
more successful in selling his sperm.43  Xytex never requested or verified his medical records 
with health care providers, nor had they looked into his criminal and educational background 
which would have been publicly available or easily accessible.44 
 The Federal District Court dismissed the complaint for failure to state claims for which 
relief could be granted.45  The district court held that the claims were ultimately for wrongful 
birth, which Georgia law does not recognize.46  The 11th Circuit affirmed this dismissal after 
 
38 Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). 
39 Id. at 736. 
40 Id. 
41 Id.at 737. 
42 Id. 
43 Id. 





analyzing possible claims and agreeing that wrongful birth—unrecognized in Georgia—was the 
only appropriate complaint for the matter.47  The Court stated that while they found the acts of 
Xytex reprehensible, “We must affirm the dismissal of all of the Zelt’s claims that necessarily 
entail pleading an injury equal to the difference in the value of a child’s life with Aggeles as the 
sperm donor and the value of the child’s life with a different donor."48  The Court took moral 
issue with labeling this controversy as “unjust enrichment.”49 
ii. Cramblett v. Midwest Sperm Bank  
 Jennifer Cramblett sued Midwest Sperm Bank in 2014 after discovering that the facility 
provided her with sperm from the wrong donor.50  Jennifer and her wife, both white themselves, 
selected a white donor but some mix-up caused them to receive sperm from a donor other than 
the one they selected.51  The sperm they received was from a black donor and the couple’s child 
was “clearly biracial.”52 Cramblett sued under a wrongful birth claim.53  The complaint claimed 
that sperm bank numbered the vials for identification with “pen and ink,” and that the records 
were not computerized.54  The judge dismissed the case holding that it was not a wrongful birth 
because the child has no health problems; courts maintain that there is no injury if the child is 
healthy.55  As the comment will discuss in a later section, wrongful birth actions are dependent 




49 Zelt v. Xytex Corp., 766 F. App'x 735, 738 (11th Cir. 2019).  (“Although the amount by which Xytex was 
enriched is easy to calculate, calling this enrichment “unjust” necessarily implies that the Zelts’ children somehow 
are worth less than they would have been worth had they been conceived using a different donor’s sperm.”) 







56 See infra at 95 
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iii. Doctors Using Own Sperm  
 There has been a great deal of press and discussion surrounding a recent string of 
incidents where families have discovered—often through direct to consumer DNA testing—that 
the sperm they received was not from their selected donor, but rather from their fertility doctor 
himself.57  The most publicized recent story has been that surrounding Dr. Cline, an Indiana 
fertility doctor who used his own sperm instead of sperm form anonymous young doctors in the 
hospital as he had told the women.58  The women who were inseminated with Dr. Cline’s sperm 
filed a complaint against him.59  Under Indiana law, however, such “infertility fraud” is not 
legally cognizable.60  More than fifty people have discovered that they are his biological children 
since the first accusation was made in 2014.61  Ongoing lawsuits in Idaho, Vermont, California, 
Canada, and the Netherlands all have similar facts: former patients or their children bringing suit 
against doctors accused of using their own sperm instead of donor sperm.62 
D. Categorization of Incidents in the Sperm Donation Industry 
 Most of the cases and controversies surrounding sperm donation fall into one of four 
categories: (1) “Unintentional False Profile”; (2) “Intentional False Profile”; (3) “Unintentional 
Switch”; or (4) “Intentional Use of Wrong Sperm.”  
Category (1), “Unintentional False Profile,” includes incidents where a sperm donor has 
deliberately or mistakenly provided false information to the sperm bank, the sperm bank is 
unaware of the falsity of the information, this information is entered into the donor profile, 
 










parents select the specific donor, and the mother is inseminated with the sperm of the selected 
donor—the selected donor just has different traits than the profile described.63   
Category (2), “Intentional False Profile,” includes incidents where a sperm donor 
provides false information to the sperm bank and the sperm bank is aware of the falsity and 
publishes the false information to a donor profile anyway, or where the sperm bank itself 
encourages or creates the false information entered into the donor profile.64  As with the first 
category, the parents then choose the donor profile representing this false information and are 
inseminated with that donor’s sperm.   
Category (3), “Unintentional Switch,” includes incidents where there is not an issue of 
false donor information, but where parents select one donor, and the sperm bank mistakenly 
provides the wrong donor’s sperm.65   
Category (4), “Intentional Use of Wrong Sperm,” includes incidents where someone—
whether it be a sperm bank employee or a medical professional performing the insemination 
procedure—intentionally provides sperm other than the selected donor sperm.66  This final 
category presents a number of interesting and complex legal questions because the most 
publicized stories have involved doctors using their own sperm instead of donor sperm.  When a 
doctor or other medical professional engages this kind of malicious deception malpractice seems 
like the most appropriate course of action.  This comment will discuss the limitations of 
malpractice actions against the sperm banking industry as a whole in a later section.  The legal 
 
63 FOODNOTE NEEDED (that case where everyone had the same genetic disease? Fragile X) 
64 See, e.g., Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). (Where an employee of the sperm bank new the 
donor’s IQ was not 160, but encouraged him to list his IQ as 160 and then published this information on his donor 
profile which the Zelts later selected).  
65 See, e.g.,  Jaqueline Mroz, Their Children Were Conceieved With Donated Sperm. It Was the Wront Sperm., (June 
3, 2019) https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html. (Where the 
Crambletts selected a white sperm donor and were inseminated by the sperm of a black donor).  
66 See, e.g., Mihir Zaveri, A Fertility Doctor Used His Sperm On Unwitting Women, N.Y. Times, (Aug. 30, 2018) 
https://www.nytimes.com/2018/08/30/us/fertility-doctor-pregnant-women.html. 
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issues surrounding malpractice actions against solely medical professionals who intentionally use 
the wrong sperm are outside the scope of this comment. 
III. EXISTING REGULATION 
A. Federal Regulation 
i. Current FDA Regulation 
 Current federal regulation of sperm donation is minimal.  The FDA classifies sperm  
under the umbrella category of “human cell, tissue, and cellular and tissue-based product” 
(HCT/Ps).67  In 2004, the FDA published three rules to regulate HCT/Ps: (1) Registration and 
listing requirements, (2) donor eligibility requirements, and (3) good tissue practices.68  The 
registration and listing rule states that “all establishments that recover, process, store, label, 
package, or distribute HCT/Ps must register with the FDA and list their HCT/Ps.”69  The donor 
eligibility requires all establishments to “screen and test cell and tissue donors for risk factors 
for, and clinical evidence of, relevant communicable disease agents or disease.”70  The good 
tissue practice rule sets forth practices that establishments should follow to prevent the spread of 
communicable disease from infected donors and HCT/Ps within the facility.71  The practices 
concern maintenance of collection practices, storage, labeling, packaging, distribution, etc.72  As 
applied to sperm donation, these FDA regulations require sperm banks to register with the 
 
67 FDA, Donor Eligibility Final Rule and Guidance Q&A, https://www.fda.gov/vaccines-blood-biologics/tissue-
tissue-products/donor-eligibility-final-rule-and-guidance-questions-and-answers (last accessed Fall 2019). 
68 Id. 
69 21 C.F.R. § 1271.21 
70 21 C.F.R. § 1271.45 




FDA,73 screen semen samples for communicable diseases,74 and implement practices that 
prevent the spread of communicable disease through the semen.75 
ii. Holes in Existing FDA Regulation 
 The eligibility rule is the only rule relevant to the testing and screening of sperm donors.  
The rule currently only requires testing for communicable disease, like HIV.  There are no 
additional testing, examination, or interviewing requirements for sperm donors; the regulations 
covering sperm donation are the same as those for blood and organ donation.  The current FDA 
regulations do not take into account the unique genetic importance of gametes—sperm and eggs.  
B. State Regulations 
 New York State Department of Health has the strictest regulations in the country 
regarding reproductive tissue banks.  In addition to the FDA-required screenings for 
communicable diseases, New York requires sperm banks to evaluate the genetic health of donors 
for specific types of heritable diseases and disorders.76  The code states, “A complete medical 
history, both individual and family, including first-degree and second-degree relatives, shall be 
obtained from each reproductive tissue donor prior to any collection of tissues for clinical use. . 
.” and continues to list a variety of malformations, genetic disorders, and behavioral factors that 
may be inheritable by a child conceived from the sperm of the donor.77  The code states that, 
except for those factors posing an increased risk for a communicable disease infection, the 
aforementioned factors do not exclude a man from being a donor, but the reproductive tissue 
bank’s medical director or attending physician shall counsel the recipient about potential risks of 
 
73 21 C.F.R. § 1271.21 
74 21 C.F.R. § 1271.45 
75 21 C.F.R. § 1271.145 




using such a donor’s sperm.78  The New York code also implements a system for inspection of 
reproductive tissue bank facilities.79   
C. Industry Self-Regulation 
i. American Association of Tissue Banks  
The American Association of Tissue Banks (AATB) is the highest-level standard-setting 
body for tissue banks in the US.80  Tissue banks receive AATB accreditation after submitting to 
onsite inspections to ensure the bank is managed by professional and appropriate staff, and has 
quality-assurance policies and procedures in place.81  There have been issues with some sperm 
banks claiming to “meet or exceed” AATB standards without having been inspected or 
accredited.82 
ii. American Society for Reproductive Medicine 
 The American Society for Reproductive Medicine (ASRM) periodically issues 
recommended guidelines for screening donors.83 The ASRM is an organization of physicians and 
professionals in the industry who use their experiences and research to make recommendations 
for best practices in the sperm donation industry. 84 These recommendations are only “industry 
standards” and compliance is voluntary. 85  




80 American Association of Tissue Banks, Accreditation, https://www.aatb.org/accreditation (last accessed Fall 
2019). 
81 Id. 
82 Sperm Bank, Sperm Bank Registration, https://www.spermbank.com/about/sperm-bank-registration (last accessed 
Fall 2019). 
83 Id. 
84 American Society of Reproductive Medicine, Vision of ASRM, https://www.reproductivefacts.org/about-




Regulation of sperm donation varies globally based on social views, healthcare systems, 
and medical technology.  While the US government and regulators have taken a largely “hands 
off” approach to sperm donation, the UK has taken the opposite approach; sperm donation in the 
UK is heavily regulated.86  The Human Fertilisation and Embryology Authority (HFEA) 
regulates all gamete (sperm and egg) donation in the UK.87  HFEA is the UK’s independent 
regulator responsible for overseeing the use of gametes and embryos in fertility treatment and 
research.88  All donors must register with HFEA prior to donating and HFEA enters all of the 
donors into a national registry.89  Since 2005, all donors in the UK must agree to be identifiable 
to any persons conceived from their donation once the person reaches the age of 18.90  The 
national registry allows the HFEA to enforce a limit on the number of children a single sperm 
donor may father to minimize the likelihood of “accidental incest.”91  A sperm donor in the UK 
may not create more than ten families, but the donor himself may choose to further limit this 
number.92 
IV. APPLICATION OF PRIVATE LEGAL REMEDIES  
 A. Existing Legal Theories 
i. Wrongful Conception 
 
86 National Gamete Donation Trust, Donation and the Law, http://www.ngdt.co.uk/sperm-donor/donation-the-law/ 
(last accessed Fall 2019). 
87 Id. 
88 Id. 
89 Human Fertilisation and Embryology Authority, Donating Your Sperm, 
https://www.hfea.gov.uk/donation/donors/donating-your-sperm/ (last accessed Fall 2019). 
90 Id. 
91 Id. 
92 Id. Sperm donors are limited to a number of families rather than a number of children because many parents using 
donor sperm may want to use the same donor to conceive multiple children. Ten families may be created by a single 
sperm donor, but each family may have multiple children from that donor.  
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 In a wrongful conception action, the argument is that the plaintiff never wanted to 
become pregnant in the first place; the legal harm is the pregnancy itself.93  In these actions, 
pregnancy-related damages are allowed, but child-rearing damages are not allowed as child-
rearing is not a legally cognizable injury.94  Some states do not allow wrongful conception claims 
for moral and policy reasons.95  Most states do allow wrongful conception actions, but claims 
alleging the use of the wrong or substandard donor sperm do not fit into the parameters of the 
action.96  In cases involving the use of a sperm donor the plaintiff clearly intended to become 
pregnant, which undermines the basic theory of “wrongful conception” claims.97  
ii. Wrongful Birth 
In a wrongful birth action, plaintiff alleges that they wanted to become pregnant, but did 
not want to give birth to a child with defects.98  A claim for wrongful birth arises from the 
argument that the parents would have opted not to conceive or would have terminated the 
pregnancy had the doctor properly advised them of the child’s risk for defects.99  Damages for 
wrongful birth actions are commonly the difference between the cost of raising a healthy child 
and the cost of raising the existing unhealthy child.100  As with wrongful conception, some states 
refuse to recognize this cause of action for moral and policy reasons.101  Even in states that do 
recognize wrongful birth, the use of the wrong sperm or less desirable sperm does not always 
 
93 Fulton-DeKalb Hosp. Auth. v. Graves, 252 Ga. 441, 314 S.E.2d 653 (1984). 
94 Id. 
95 NOTE: Malpractice Claims Resulting from Negligent Preconception Genetic Testing: Do These Claims Present a 











produce an unhealthy child.102  The resulting child is most often perfectly healthy, just having 
different superficial attributes than the parents had desired.103  The issue becomes more complex 
if the donor has heritable physical or mental health problems, but the child has not yet 
manifested any problems and only has a certain probability of developing the problem.  Courts 
have grappled with how to properly award damages in these scenarios.  Courts are also unwilling 
to make any damage calculations based on the theory that a child born from one sperm donor is 
worth less than one born from another donor.104   
iii. Malpractice 
Sperm banks primarily operate independently from fertility clinics or other medical 
practices.105  After the parents select the sperm through the bank, the sperm bank delivers the 
donor sperm to the medical practice for insemination.106  The doctor has no more of a way to 
know whether or not the delivered vials contain the correct sperm than do the parents.  Plaintiffs 
can only bring malpractice suits against medical professionals, so if it was the sperm bank that 
caused a mix-up of sperm the plaintiff cannot bring a malpractice claim because sperm banks 
and their employees are not medical professionals.107   
Malpractice suits could be appropriate in the cases of doctors using their own sperm to 
inseminate patients since the doctor is the party committing the deception.108  While plaintiffs 




104 See Zelt v. Xytex Corp., 766 F. App'x 735, 738 (11th Cir. 2019). See also Jaqueline Mroz, Their Children Were 
Conceived With Donated Sperm. It Was the Wrong Sperm., (June 3, 2019) 
https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html. 
105 NOTE: Whose Sperm Is It Anyways In The Wild, Wild West Of The Fertility Industry?,34 Ga. St. U.L. Rev. 
847. (Many fertility clinics will have a “preferred list” of sperm banks they recommend, but normally the clinic and 
sperm banks are entirely seperate entities) 
106 Id. 
107 Id. 
108 FOOTNOTE NEEDED (need to find which Law Review article this came from)  
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doctors, the same issues as discussed above will arise with characterizing the injury and 
calculating damages.  The feasibility of malpractice claims in this context, and the lack of legal 
recourse against doctors specifically is largely outside the scope of this comment.  
iv. Contract 
 Contract claims are of minimal use to parents in cases where they receive the incorrect or 
“lower quality” sperm.  Even if the parents prove that the sperm bank breached their contract, the 
sperm bank can often avoid legal liability by relying on the doctrine of excuse, which applies 
when the breaching party’s failure to perform “causes little material harm.”109  Where incorrect 
or “lower quality” sperm is used, parents might be required to prove that the resulting genetic 
qualities of the resulting child differ materially from the agreed upon terms of the contract.110  
Parents will have to prove that these unwanted genetic qualities “are not merely incidental to the 
contract they signed but that go to its very purpose.”111  If argued correctly, parents potentially 
stand some chance of recovery if the resulting child has inherited a genetic disease or deformity 
as a result of the sperm bank’s actions.  Parents in these situations may be able to successfully 
argue that they contracted for a healthy child free of genetic diseases, and that it was a material 
breach for the sperm bank to furnish an unhealthy child.  However, this legal theory would be 
inapplicable to the types of incidents that are more likely to occur where the child is healthy but 
possesses a different genetic makeup than the parents intended.  In cases where the child is 
healthy but having undesirable superficial genetic qualities the parents must argue that they did 
not just contract for sperm to produce a healthy child, but for sperm to produce a healthy child 
 
109 ESSAY: REPRODUCTIVE NEGLIGENCE, 117 Colum. L. Rev. 149, 174 (January, 2017).  
110 Id. 
111 Id. (citing Jacob & Youngs, Inc. v. Kent, 129 N.E. 889, 890 (N.Y. 1921).  (holding that where builders had used a 
different brand of pipes than the one specified in the agreement, and the pipes used were of the same quality, 
contract law afforded the property owner no protection.) 
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with specific genetic qualities: sperm to produce a child with no inherited predisposition for 
mental illness, sperm to produce a white child, sperm that is likely to produce a child with a 
specific physical attributes.  These types of arguments will likely be quashed by the materiality 
doctrine.112  
 Looking to another aspect of contract law, courts will not typically award damages to 
compensate for mental distress or emotional trauma resulting from a breach of contract.113  
However, most jurisdictions recognize special circumstances in which damages for emotional 
distress are recoverable.114  These circumstances arise where the defendant knew or should have 
known of the special circumstances at the time the defendant entered into the contract.  These 
contracts are those that are “related to matters which concern directly the comfort, happiness, or 
personal welfare of one of the parties, or the subject matter of which is such as directly to affect 
or move the affections, self-esteem, or tender feelings of that party.”  Courts have held that such 
mental or emotional distress claims are appropriate for cases of contracts for mortuary and 
crematorium services, or contracts for childcare.115  Mental or emotional distress contract claims 
are arguably appropriate in cases involving wrongdoing on the part of a sperm bank.  It is 
undoubtedly upsetting for parents to discover that the father of their biological child is not the 
person they selected.  This selection of donor is a deeply personal choice.  The mother in 
particular may have emotional distress claims because of the violation she may feel after she was 
inseminated with sperm other than the sperm she chose.116  It is possible that emotional and 
 
112 ESSAY: REPRODUCTIVE NEGLIGENCE, 117 Colum. L. Rev. 149, 174 (January, 2017). 
All major sperm banks have parents sign a boilerplate contract stating that any specific genetic characteristics are 
not a guaranteed “term” of the contract.  
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mental distress claims could be recoverable here.  However, damage calculations for these types 
of claims are still difficult, and as a matter of public policy courts may be opposed to allowing 
parents to claim that their child has brought them emotional or mental distress.  
 
B. Public Policy Concerns  
 Any private legal action against sperm banks in these incidents is going to necessitate a 
finding of an injury and calculation of damages.  The ultimate “injury” in these cases is a child 
with a different genetic makeup than the parents had intended.  As a matter of public policy, 
courts are reluctant to conclude that the existence of a child is an “injury” or to make calculations 
that one child is worth less than another.117  What is the dollar value of a healthy child?  How 
much less is an unhealthy child worth?  How much less is a child with the “wrong” physical 
appearance worth?  How much less is the biological child of a man with a criminal record and 
average IQ worth than the child of a Ph.D. candidate with an IQ of 160?118  It is easy to see why 
courts fail to recognize these claims as legally cognizable.  Courts do not want to stretch 
common law or statutory rights of actions past their outer limits to encompass this class of 
controversies that is impossible to ethically fit within the confines of existing doctrines.  The 
court is best to defer to the legislature on these legal questions that encompass such profound 
public policy concerns. 
C. Creation of New Statutory Rights of Action  
i. Emerging Concept of “Fertility Fraud”  
 
laws-go-after-misuse-of-sperm.  (A woman who was inseminated by her doctor’s own sperm instead of her selected 
donor sperm commented “I felt like I was raped 15 times and didn’t know it.”) 
 
117 See generally, Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019).  
118 See, e.g., Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). 
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 As stories surface of doctors intentionally using their own sperm instead of the promised 
donor sperm, or instead of the patient’s husband’s sperm, outrage at the limited legal recourse 
has led some states to push for new legislation that would criminalize what has been labeled as 
“fertility fraud.”119  This is a step in the right direction indicating that legislators understand the 
severity of this act, but this criminalization would only apply in the category of “Intentional Use 
Of Incorrect Sperm” and perhaps extending to severe misrepresentations in the category of 
“Intentional False Donor Profile.”   Many of the incidents that occur in the sperm donation 
industry seem to result from negligence: sperm banks are negligent in delivering the correct 
sperm to the correct parents, or in verifying the representations made by the donor.  These 
“fertility fraud” laws would offer no protection to parents who were victims of mere negligence 
rather than malicious misrepresentations.  
ii. Public Policy Concerns with Creating a Statutory Right 
 Legislators should be hesitant to create a statutory right of action that would give people 
a right of action based on the “undesirable” genetic makeup of a child.  It seems appropriate that 
doctors and sperm banks that make intentional misrepresentations face some type of punitive 
action.  As the comment will later discuss, a stricter regulatory scheme should exist with a 
punitive system for failure to comply with certain standards.  However, giving parents a private 
right of action against sperm banks raises some major and unavoidable policy concerns.  First, as 
discussed throughout the preceding section, the issue of damages will always raise ethical 
concerns in this context.  More importantly, perhaps, is the concern of how such litigation would 
affect the child in question.  It would be emotionally and psychologically devastating for a child 
to discover that his or her parents sued because they were unhappy with his or her genetic 
 
119 Sarah Zhang, A Decades-Old Doctor’s Secret Leads to New Fertility-Fraud Law, The Atlantic, (May 7, 2019), 
https://www.theatlantic.com/science/archive/2019/05/cline-fertility-fraud-law/588877/. 
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characteristics.  It is troubling to consider how the children at issue in cases like Zelt and 
Cramblett will feel when they are old enough to search their name online and read the claims of 
alleged damages their own parents made.  Sperm banks should certainly be held to a higher 
standard.  Parents who have been victims of misrepresentation or negligence by sperm banks are 
right to be upset.  Nonetheless, the emotional and psychological well-being of the children in 
these cases seems to be too high a cost to pay for a statutory right of action.   
V. PROPOSED REGULATORY SCHEME  
 As demonstrated by the preceding sections, traditional legal remedies offer little recourse 
to parents.  Existing private remedies cannot comfortably encompass the type of injury alleged in 
complaints brought by parents against sperm banks, and there are major public policy issues 
involved with legislators creating statutory rights of action.  Sperm banks have been getting 
away with egregious acts of negligence and misrepresentation for decades, confident in their lack 
of legal accountability and shielded by the reluctance of customers to publicize any incidents 
because of the intensely private nature of sperm donation.  The emphasis on donor privacy and 
anonymity makes transparency impossible: the very nature of sperm donation allows the industry 
to operate under the strictest secrecy.  
 Regulation is crucial where the nature of the industry prevents people from protecting 
themselves.  Regulation becomes even more crucial where it is the only line of defense. 
Regulation is most important where, as here, there is minimal threat of civil liability, no criminal 
action, and little to otherwise deter actors in the industry from taking advantage of people. 
 Current FDA regulation of the industry is minimal at best.  As discussed above, 
applicable FDA regulations focus on preventing the spread of communicable disease.120  There 
 
120 FDA, Donor Eligibility Final Rule and Guidance Q&A, https://www.fda.gov/vaccines-blood-biologics/tissue-
tissue-products/donor-eligibility-final-rule-and-guidance-questions-and-answers (last accessed Fall 2019). 
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are no regulations unique to sperm banking; the FDA regulates sperm no differently than blood 
and organs.121  The current regulations do not account for the unique genetic quality of sperm.122  
These regulations do not account for the fact that sperm banks are selling sperm online like a 
retail item on websites formatted similarly to online dating sites.123  The FDA should implement 
a new regulatory scheme that is specific to gametes.  
 This section of the comment will propose a regulatory scheme intended to increase 
protections for parents by increasing accountability in, and oversight of the sperm donation 
industry.  
A. Who Should Regulate The Sperm Donation Industry 
 The FDA has broad regulatory authority and has responsibilities “closely related to those 
of several other government agencies.” 124  Among other things, the FDA regulates biologics 
including blood and blood products, and tissue and tissue products. 125  The FDA considers 
human reproductive tissue, sperm and eggs, tissue products and, thus, sperm is currently 
regulated by the FDA. 126  It seems appropriate that the FDA continues to remain the regulating 
authority of sperm.  One might argue that the Federal Trade Commission (FTC) would be an 
appropriate regulatory authority.  The FTC regulates advertising and “protects consumers by 
stopping unfair, deceptive, or fraudulent practices in the marketplace.127  There are clearly 





124 FDA, What Does the FDA Regulate, https://www.fda.gov/about-fda/fda-basics/what-does-fda-regulate (last 
accessed Fall 2019).  
125 Id.  
126 FDA, Reproductive Tissue Donation, https://www.fda.gov/vaccines-blood-biologics/safety-availability-
biologics/what-you-should-know-reproductive-tissue-donation (last accessed Fall 2019).  
127 FDA, What Does the FDA Regulate, https://www.fda.gov/about-fda/fda-basics/what-does-fda-regulate (last 
accessed Fall 2019). 
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sperm donation industry operates much like any other distributor of a consumer good.  
Consumers of donor sperm could potentially stand to benefit if the FTC applied its standards and 
regulations to the sperm donation industry.  However, the creation of human life is far more 
complex and important than almost any other consumer transaction.  Being that the FDA is 
already involved in the regulation of sperm, albeit only minimally, it seems most appropriate that 
the FDA continue to be the regulatory authority overseeing the sperm banking industry.  
 An alternative option would be to create an independent regulatory agency, like the UK’s 
HFEA, to oversee and regulate all embryo and gamete operations.128  This is a compelling option 
given the unique characteristics of gametes, but this would be a huge leap to go from no 
regulation unique to gametes, to an entirely new regulatory agency devoted specifically to the 
industry.  Making such a drastic jump in degree of regulation is just unrealistic at this time.  As 
scientific advancements increase the number of ART options, and as gene editing of embryos 
looms on the horizon, the feasibility and necessity of creating such an independent regulatory 
agency to specifically oversee gametes and embryos may increase.129  
B. Recommended Regulation 
i. Goals 
 The overarching goal of the recommended regulatory scheme is to increase protection for 
consumers of donor sperm.  New regulation would achieve this goal by increasing oversight of 
and accountability in the sperm donation industry.  Before articulating a regulatory 
recommendation, it is important to consider the specific aims of the regulation. What is the 
 
128 See infra 86 
129 Emre Selli, Scientific Priorities for Assisted Reproduction in the 21st Century, (Feb. 20, 2019), https://www.ivi-
rmainnovation.com/science-priorities-assisted-reproduction-21st-century/ 
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regulation trying to prevent and require?  What restrictions and requirements would protect 
consumers from the harm they currently face in the industry? 
 It is helpful to consider each of the previously articulated categories of incidents resulting 
from sperm banks’ conduct to determine what types of regulatory measures could prevent or 
minimize each type of incident.  First, “Unintentional False Profile” incidents are a result of an 
omission by the sperm bank—a result of the sperm bank’s failure to adequately confirm the 
background information the donor has provided about himself.130  Regulations that set a standard 
for how sperm banks confirm donor information could help prevent this type of incident.  
 The second category of incidents, “Intentional False Information,” is the result of an 
affirmative act by the sperm bank.  The sperm bank is either publishing donor information it 
knows to be false, or the sperm bank itself is encouraging the donor to provide false information, 
or the sperm bank is just unilaterally publishing false information onto donor profiles.131  Since 
this is an affirmative act by the sperm bank regulators cannot prevent it by implementing more 
stringent confirmation checks of donor information; this type of conduct must be deterred by the 
threat of some punitive action.  Without much threat of legal remedy, there is currently little to 
deter sperm banks from exaggerating or outright lying on donor profiles to increase profits by 
listing more “desirable” donors.   
 The third category of incidents, “Unintentional Switch,” is a result of negligence by the 
sperm banks.  Some error in recording, labeling, storage, shipping, or the like results in a doctor 
inseminating the mother with sperm from someone other than the donor selected.132  
 
130 See, e.g. Ariana Eunjung Cha, The Children of Donor H898, WASH. POST (Sept. 18, 2019)  
131 See, e.g., Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). 
132 See, e.g., Jaqueline Mroz, Their Children Were Conceived With Donated Sperm. It Was the Wrong Sperm., (June 
3, 2019) https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html. (describing 
an incident where a mother was inseminated with sperm other than that of the donor she and her partner selected).  
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Unfortunately, accidents like these are sometimes just the result of unavoidable human error that 
would be unpreventable even with extensive regulation.  However, some regulatory standards 
should require that sperm banks be using modern and effective systems to minimize the 
likelihood of error.  
 The fourth category, “Intentional Use of Wrong Sperm” can only be prevented by 
creating a punitive system within the regulatory scheme to deter such behavior.  As discussed 
throughout the preceding sections, there is no existing legal remedies to hold doctors or sperm 
banks accountable for these actions.  The same punitive system that would effectively deter 
intentional misrepresentations would be used to deter intentional use of wrong sperm.   
 In all categories of incidents, the secrecy that necessarily surrounds sperm donation 
allows the sperm banks to continue to get away with this type of conduct.  Sperm donors and 
parents rely on and expect anonymity; the privacy of the donor and of the parents and their 
resulting children are at the core of the entire process.  Sperm banks can easily blame the secrecy 
and lack of transparency on the need to protect these privacies, but it instead offers cover for 
sperm banks to continue to get away with practices that would not likely be tolerated in any other 
industry.  Some implementation of facility inspection is essential to ensure that sperm banks are 
operating in accordance with regulations since consumers have no way of overseeing this 
themselves.  
 There are four overall objectives for increased FDA regulation for sperm banks.  First, to 
implement a system of confirming information provided by donors.  Second, to enact punitive 
actions to punish and deter intentional misrepresentations or intentional use of incorrect sperm.  
Third, to require certain standards for labeling, organization, and distribution practices.  Fourth, 
to establish a system for the inspection of facilities and practices at those facilities.  
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ii. Donor Profile Verification Requirement 
 Sperm banks must verify any donor information represented on the donor’s 
profile.  Regulations need not require that specific types of documents or other type of proof be 
produced.  However, verification must involve getting tangible proof from either official 
documentation or confirmation by an appropriate third party.  Regulations would ideally list 
examples of appropriate verification practices: requiring official transcripts from claimed 
educational institutions to prove degree, GPA, or honors; requiring W-2s to prove employment 
in a specific field; requiring official reports from testing organizations to prove SAT scores or 
IQ; requiring medical files with no gaps greater than eighteen months to verify medical 
background.  Sperm banks would not need to use these exact methods of verification to comply 
with regulations.  For example, perhaps the sperm bank could receive a list of all pertinent 
medical history from the donor’s doctor,133 so the sperm bank need not comb through the donor’s 
medical history itself. 134 
Under this proposed regulatory scheme Xytex of the Xytex v. Zelt case would have 
violated the requirement to verify donor profile information.135  Xytex failed to verify degrees, 
current educational program, and testing scores of the donor.136  Xytex could have asked for a 
number of different types of easily accessible proof—transcripts, bills, official score reports, 
etc.—to verify the claims made by the donor.    
 
133 The donor would have to give permission for his doctor to release this information to sperm banks as not to 
violate HIPPA.  
134 Not all of a donor’s medical history would be relevant to sperm banks, only history pertaining to heritable issues. 
For example, if a potential donor had a severe knee injury it would be unnecessary for the sperm bank employees to 
read through pages and pages of medical reports pertaining to this injury because this would have no effect on 
donor’s potential offspring.  
135 See, e.g., Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). 
136 Id. 
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The regulations should also state that donors may rely on any documents or other form of 
proof provided per the bank’s requirements so long as it is not unreasonable for the sperm bank 
to do so.  If a donor had somehow provided falsified documents, the sperm bank should only be 
found to have violated FDA regulation for publishing this information to a donor profile if it was 
unreasonable for the sperm bank to rely on the document or form of proof.  For example, it 
would be unreasonable for a sperm bank to rely on an “unofficial” transcript as proof of 
enrollment in an educational program.  However, a sperm bank would have fulfilled their duty to 
reasonably verify the information if an official transcript with the seal of the institution or 
delivered by the institution was found to be falsified; it would not be unreasonable for a sperm 
bank to rely on such documentation.   
 In addition to requiring sperm banks to verify donor information, the proposed FDA 
regulation would further require sperm banks to disclose its method of verification to parents.  
The flexibility in the regulatory scheme would allow each sperm bank to decide what specific 
forms of proof it wants to require donors to present.  Some banks will likely do the bare 
minimum to comply with this verification requirement while other banks go above and beyond 
this requirement.  Regardless, sperm banks must indicate what it means for information to have 
been “verified” means at their facility.  Does verifying a donor’s educational status mean 
obtaining three separate types of documentation confirming the degree, or does it just mean 
getting a single transcript?  Either method would be in compliance with regulation, but parents 
have a right to know what method was used in screening the biological father of their child.  
Some parents may be comfortable relying on just the minimum regulatory requirement while 
other parents may want—and be willing to pay more for—additional assurance.  FDA 
 29 
regulations would require the sperm bank to make its donor verification procedures clearly 
known on each donor profile. 
 The regulations would also require that the sperm bank disclose its method of verification 
for each piece of information with sufficient detail so that parents are not confused or mislead.  
For example, many sperm banks make claims that donors have undergone genetic testing.  The 
general public may not understand what “genetic testing” means in this context.  Sperm banks 
will almost certainly be testing for specific known, high-risk traits; banks will not be running a 
full genome test on every donor.  This means that sperm banks can confirm whether or not the 
donor has a high likelihood of passing on the certain heritable diseases that it specifically tests 
donors for.  However, the donor could still have a high likelihood of passing on a heritable gene 
for some trait that was not being tested for.  Full genome testing is not necessary or practicable.  
It is necessary for parents to understand that when a sperm bank indicates that a donor’s genetic 
testing did not indicate any heritable diseases, or only had a low risk of some disease, that it does 
not mean that the donor has been tested for every possible heritable disease.137 
If a sperm bank is unable to verify certain claims made by the donor, this donor need not 
automatically be excluded from becoming a donor.  The sperm bank may still allow the man to 
donate sperm, but the donor profile must not reflect any information that is not verified. 
However, family medical history is a piece of information that most parents want to know but is 
impossible to verify.  Verifying this information would require privacy waivers from not just the 
donor, but his parents, siblings, and grandparents; obtaining medical history verification from all 
of these people is just not feasible.138  Therefore, sperm banks may disclose the donor’s reported 
 
137 What are Whole Exome Sequencing and Whole Genome Sequencing, NIH, 
https://ghr.nlm.nih.gov/primer/testing/sequencing (last accessed Fall 2019).  
138 Men likely do not share their decision to become a sperm donor with many people in their lives.  These relatives 
of the donor may also be unwilling to share their full medical histories for this purpose.  
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family medical history on the donor profile—otherwise this information could never be included 
on donor profiles.  However, sperm banks must make it clear on the profile that the family 
medical history is only reported by the donor and not able to be verified.   
ii. Specimen Storage and Maintenance Requirement 
 New FDA regulation should require that all sperm banks utilize a computerized system to 
organize, maintain, and distribute specimen.  All specimen containers should be labeled with a 
barcode—or an equivalent—and an alphanumeric code.  Anytime a specimen is collected, 
stored, moved, or distributed the barcode should be scanned for verification by a computer 
program, and the alpha-numeric number should be checked by the human employee.  This would 
also create a computerized record of any date and time the specimen was moved.  Each time 
parents select a donor the donor profile should be linked to the alphanumeric code and barcode 
which should be fixated automatically on the parents’ order or profile.  This computer-dependent 
system would help to prevent mix-ups like the one in Cramblett v. Midwest Sperm Bank where 
the plaintiff claimed that sperm bank labeled specimen with pen and paper.  With the advanced 
state of computer technology there is no excuse for sperm banks to not use a computer program 
to ensure accurate specimen handling.  
iii. Punitive Action for Intentional Misrepresentations 
 FDA regulation should outline a punitive cause of action for sperm banks and employees 
who knowingly or intentionally advertise false information about donors on the donor profiles.139  
Regulations should classify such acts as “misbranding.”140  Fines and/or criminal action should 
be determined based on the nature of the misrepresentation such that misrepresentations about 
 
139 21 U.S.C. § 331. Prohibited Acts. 
140 Id. 
 31 
something more superficial, like educational degree, are punished less severely than 
misrepresentations about medical or mental health background.   
 These punitive actions should also apply against any medical professionals—doctors, 
nurses, etc.—that are responsible for inseminating women with donor sperm.  If a doctor were to 
knowingly or intentionally inseminate a woman with the incorrect sperm, the doctor would also 
be subject to any fines or criminal action.  This addition to the regulations would provide parents 
with some opportunity for punitive action against the doctors who used their own sperm to 
inseminate unknowing women.  Perhaps future legislation will allow parents to bring more 
severe “fertility fraud” criminal action or malpractice actions against doctors who take these 
deliberate deceptive actions. For now, including this venue for punitive action against medical 
professionals will give parents at least some method of recourse.   
iv. Enforcement Action 
 Failure to comply with FDA standards should result in enforcement action.141  The level 
of the enforcement action by the FDA should be aligned with the nature and seriousness of the 
violation.142  A first instance of failure to comply with standards where there was no resulting 
harm (harm being a parent conceiving a child with misrepresented or incorrect sperm) would 
result in a warning letter.143  Instances where harm did occur as a result of negligence—
inadequate steps to confirm background, or inadequate specimen management resulting in a 
switch—but not an intentional misrepresentation would result in a fine.144  Incidents where harm 
 
141 FDA, Enforcement Action, https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-






occurred as a result of misrepresentation would result in a higher fine.145  The FDA could file 
injunctions against sperm banks to cease noncomplying actions.146  Seizures and destruction of 
specimens could occur if the FDA believed specimens to be mislabeled or misbranded.147  Sperm 
banks could lose FDA licensing all together after repeat violations.148  
 
 
 v. Inspection 
 Currently, only New York State requires inspections of sperm donation facilities.  
Ongoing inspection of facilities and practices is the best way to ensure compliance with 
standards.  Inspection is especially important in an industry such as the sperm donation industry 
where the emphasis on anonymity and privacy allows the industry to operate with effectively no 
transparency.   
 Under the proposed regulatory scheme sperm banks would be subject to biennial 
inspections as well as unannounced inspections.  During inspections, an FDA inspector would be 
ensuring compliance with both donor profile verification requirements and specimen 
maintenance requirements.  To inspect specimen maintenance programs the inspector would 
observe employee practices in collection, storage, and distribution.  The inspector would ensure 
that the sperm bank was using an appropriate computer program, employees were being trained 









 Inspections for compliance with donor profile verification requirements would be a bit 
more tedious.  Overall, the inspector would be looking to confirm that the information on donor 
profiles was actually verified by the sperm bank and that the verification process was accurately 
represented to the parents viewing donor profiles.  This would require the inspector to observe 
three different aspects of the sperm banks operations.  First, the inspector would observe donor 
interview procedures to see that employees are asking donors the right questions and gathering 
the correct preliminary information.  Second, the inspector would review randomly selected 
confidential donor files and compare them to the donor profiles on the sperm bank’s website.  
The inspector would be looking to see that every piece of information on the donor profile was 
corroborated by some compliant verification document.  Third, the inspector would review the 
website and profiles to ensure that the method of verification the sperm bank has promised 
parents is the method the sperm bank actually used; if the sperm bank says educational 
background was verified by a transcript and a diploma photocopy then the inspector needs to 
find both of those documents in the sperm bank’s file on the donor.  If a sperm bank is found to 
be in violation of any of the regulation requirements, then an appropriate enforcement or punitive 
action would be taken.  
C. Potential Limitations of Proposed Regulation 
i. Over-regulation 
 It is important to strike a balance between too little and too much regulation over an 
industry.  Too little regulation and consumer safety and protection are at risk, but too much 
regulation also has serious economic costs, the brunt of which falls on the lowest income 
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consumers.149  Assisted reproductive technologies in their loosely regulated state are already 
quite expensive, and many commentators note that assisted reproductive technology is a luxury 
only available to the wealthy.150  Lower income Americans facing medical or social infertility 
already struggle to access ART.  Enforcing regulatory requirements in the sperm banking 
industry will unavoidably raise expenses for sperm banks which they will pass off to consumers 
in increased prices.  While the wealthy will be unaffected by the increase, this increased expense 
will make donor sperm even more burdensome or entirely unaffordable to lower income parents.   
 
ii. Under Regulation 
 When compared to the UK’s HFEA, this proposed regulation seems under inclusive.151  
As discussed above, the UK has an independent regulatory agency, a national sperm donor 
registry, and a limit on the number of families that a donor may create.152  This comment has 
already discussed the infeasibility of jumping from no unique regulation for the sperm banking 
industry to establishing an entire independent regulatory agency.  A limit on the number of 
families that a donor may create is important.153  There are concerns about accidental 
consanguinity from a population-genetics perspective.154  The American Society for 
Reproductive Medicine recommends a limit of 25 births per a population of 800,000 but, of 
 
149 Adam Millsap, Too Much Regulation Hurts America’s Poor, (July 23, 2019) 
https://www.forbes.com/sites/adammillsap/2019/07/23/how-too-much-regulation-hurts-americas-
poor/#3a2411bf271f 
150 Ada Dieke, et al., Disparities in Assisted Reproductive Technology Utilization by Race and Ethnicity (June 2017), 
accessed at, https://www.liebertpub.com/doi/abs/10.1089/jwh.2017.6467?journalCode=jwh  
151 Supra (talk about HFEA stuff) 
152 National Gamete Donation Trust, Donation and the Law, http://www.ngdt.co.uk/sperm-donor/donation-the-law/ 
(last accessed Fall 2019). 
153 American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 






course, there is no assurance that this recommendation will be followed.155  Tracking the number 
of children born from a donor requires parents to report if insemination is successful, but there is 
no assurance that parents report births resulting from purchased sperm.156  The biggest obstacle 
to complying with this recommended limit, however, is the reality that each sperm bank operates 
entirety independently.157  There is no national donor registry, so a donor’s sperm may result in 
however may births at one sperm bank, but then the donor can go to another sperm bank, say he 
has never donated before, and there would be no way for the sperm banks to know of the other 
donations and conceived children.158  
 Implementing a national sperm donor registry system has its pros, including allowing an 
enforced limit on births per donor.159  A national registry would also increase regulatory 
oversight and would arguably be a good addition to the proposed regulations above.160   
However, national registries tend to decrease the number of men willing to donate sperm.161  
Donating to a private, independent clinic seems to make men feel more comfortable with the 
anonymity of the whole process.162  As with creating an independent regulatory agency, creating 
a national donor registry would also be a fairly big leap from virtually no regulation of the sperm 






159 National Gamete Donation Trust, Donation and the Law, http://www.ngdt.co.uk/sperm-donor/donation-the-law/ 
(last accessed Fall 2019). 
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(last accessed Fall 2019). 
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sperm donation industry but implementing a basic system of standards and enforcement is a 
more realistic primary goal for the time being.  
VI. CONCLUSION 
 An increasing number of same-sex couples, single women, and infertile couples are 
relying on sperm donation to grow their families.  The current FDA regulation does nothing to 
deter negligence and misrepresentation, and the harm parents suffer does not align with existing 
common law legal remedies.  These deficiencies undermine the parents’ control and autonomy in 
a field where parents have no choice but to place total trust in sperm banks and their employees.  
Since creating legal remedies that classify the birth of a child as an injury raises substantial 
ethical and policy concerns, regulation is the best way to protect parents.  A regulatory scheme 
that increases oversight and accountability in the sperm banking industry will be a major step 
towards taming the “wild west” of assisted reproductive technologies, and making the sperm 
donation process more reliable for the parents who must rely on it to grow their families.      
